Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
9.35
-0.42 (-4.30%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Nuvectis Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
219105145110--
Market Cap Growth
-27.66%-27.66%31.58%---
Enterprise Value
2008712286--
Last Close Price
9.355.418.347.50--
PB Ratio
18.7710.7611.847.72--
P/TBV Ratio
10.7610.7611.847.72--
Quick Ratio
2.082.082.743.232.37-
Current Ratio
2.092.092.753.302.41-
Return on Equity (ROE)
-173.41%-173.41%-168.51%-206.81%-609.74%-
Return on Assets (ROA)
-65.64%-65.64%-69.14%-83.30%--
Return on Capital (ROIC)
-113.21%-113.21%-103.60%-122.13%-171.30%-
Earnings Yield
-8.69%-18.18%-15.40%-17.38%--
Buyback Yield / Dilution
-10.01%-10.01%-22.90%-196.55%-9.44%-
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q